Downregulation of lymphocyte mitogenesis by breast cancer-associated p43
- 15 July 1994
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 82 (1) , 105-111
- https://doi.org/10.1016/0304-3835(94)90153-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Expression of p43 in breast cancer tissue, correlation with prognostic parametersCancer Letters, 1992
- Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancerInternational Journal of Cancer, 1992
- Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancerBreast Cancer Research and Treatment, 1992
- Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth controlBlood, 1991
- The use of oncofetal ferritin-bearing lymphocytes as a marker for the screening, diagnosis, and follow-up of patients with early breast malignancy screening of 3400 womenCancer, 1989
- INHIBITORY EFFECTS OF ISOFERRITINS FROM TUMOUR AND NON-TUMOUR TISSUES ON E-ROSETTE FORMATIONThe Lancet, 1984
- Masking of Receptors for Sheep Erythrocytes on Human T-Lymphocytes by Sera From Breast Cancer Patients 2JNCI Journal of the National Cancer Institute, 1977
- Immunobiology of Operable Breast CancerAnnals of Surgery, 1976
- Decreased T-Lymphocytes in Patients with Mammary CancerAmerican Journal of Clinical Pathology, 1976
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957